BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31027678)

  • 1. Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study.
    Lindh-Åstrand L; Hoffmann M; Fredrikson M; Hammar M; Spetz Holm AC
    Maturitas; 2019 May; 123():55-60. PubMed ID: 31027678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy might be underutilized in women with early menopause.
    Lindh-Åstrand L; Hoffmann M; Järvstråt L; Fredriksson M; Hammar M; Spetz Holm AC
    Hum Reprod; 2015 Apr; 30(4):848-52. PubMed ID: 25662809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study.
    Everhov ÅH; Nyberg T; Bergmark K; Citarella A; Rådestad AF; Hirschberg AL; Smedby KE
    Menopause; 2015 Jun; 22(6):633-9. PubMed ID: 25405572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient use of menopausal hormone therapy in Swedish women with early or premature menopause caused by bilateral oophorectomy: a register-based study.
    Sundell M; Brynhildsen J; Fredrikson M; Hoffmann M; Spetz Holm AC
    BJOG; 2024 Mar; 131(4):500-507. PubMed ID: 37667667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
    Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
    Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden.
    Lindh-Åstrand L; Hoffmann M; Hammar M; Spetz Holm AC
    Climacteric; 2015 Feb; 18(1):53-62. PubMed ID: 24742038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey.
    Gass ML; Stuenkel CA; Utian WH; LaCroix A; Liu JH; Shifren JL;
    Menopause; 2015 Dec; 22(12):1276-84. PubMed ID: 26382314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study.
    Sidorchuk A; Isomura K; Molero Y; Hellner C; Lichtenstein P; Chang Z; Franck J; Fernández de la Cruz L; Mataix-Cols D
    PLoS Med; 2018 Aug; 15(8):e1002635. PubMed ID: 30086134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary embolism in menopausal hormone therapy: a population-based register study.
    Sundell M; Spetz Holm AC; Fredrikson M; Hammar M; Hoffmann M; Brynhildsen J
    Climacteric; 2022 Dec; 25(6):615-621. PubMed ID: 36218141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
    Persson I; Yuen J; Bergkvist L; Schairer C
    Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based cohort study on the use of hormone treatment and endometrial cancer in southern Sweden.
    Epstein E; Lindqvist PG; Olsson H
    Int J Cancer; 2009 Jul; 125(2):421-5. PubMed ID: 19326453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hormone therapy in Swedish women aged 80 years or older.
    Järvstråt L; Spetz Holm AC; Lindh-Åstrand L; Hoffmann MJ; Fredrikson MG; Hammar ML
    Menopause; 2015 Mar; 22(3):275-8. PubMed ID: 25051289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Ji J; Sundquist J; Sundquist K
    Int J Cancer; 2018 May; 142(10):2003-2010. PubMed ID: 29270993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
    Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
    PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.